Changing trends in the epidemiology of gastric cancer.

epidemiology gastric cancer mortality prevalence

Journal

Medicine and pharmacy reports
ISSN: 2668-0572
Titre abrégé: Med Pharm Rep
Pays: Romania
ID NLM: 101742144

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 01 05 2022
accepted: 29 05 2022
medline: 14 8 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: ppublish

Résumé

Currently being the seventh most prevalent form of cancer worldwide, and the fifth most common cause of cancer-related death, based on GLOBOCAN 2020 data, gastric cancer is still an important public health problem, despite its dropping incidence. Regions around the world are still at high-risk, mostly in populations with a high prevalence of Helicobacter pylori infection or a carcinogenic favorable diet. Gastric cardia cancer incidence is on the rise in some areas. Great steps were made in the last decades in understanding the pathogenesis of gastric cancer and its risk factors. Host genetic polymorphisms play a quintessential role in disease outcome. Helicobacter pylori eradication and endoscopic surveillance are the most effective options to further decrease gastric cancer incidence. Surgery is required for a curative treatment in most cases. This review summarizes the latest worldwide epidemiological data of gastric cancer and aims to provide an accessible and credible source of evidence for physicians who assess risk factors for gastric cancer.

Identifiants

pubmed: 37577012
doi: 10.15386/mpr-2538
pii: cm-96-229
pmc: PMC10419679
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

229-234

Références

N Engl J Med. 2001 Sep 13;345(11):784-9
pubmed: 11556297
Cancers (Basel). 2019 Apr 28;11(5):
pubmed: 31035365
Cancer Res. 2010 Feb 15;70(4):1430-40
pubmed: 20124475
J Clin Oncol. 2010 Jun 20;28(18):2952-7
pubmed: 20479409
Cancer Epidemiol Biomarkers Prev. 1996 Jan;5(1):47-52
pubmed: 8770466
Cancer Res. 2012 Sep 1;72(17):4383-93
pubmed: 22751462
Lancet. 1996 Jul 20;348(9021):150-4
pubmed: 8684154
Gut. 2012 May;61(5):673-84
pubmed: 22315472
Aliment Pharmacol Ther. 2012 Jul;36(1):48-56
pubmed: 22554233
Am J Gastroenterol. 1999 Sep;94(9):2373-9
pubmed: 10483994
J Natl Cancer Inst. 1975 Jul;55(1):101-6
pubmed: 808633
Gastrointest Endosc. 2013 Aug;78(2):216-24
pubmed: 23867371
Int J Cancer. 2005 Mar 20;114(2):237-41
pubmed: 15540224
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3761-6
pubmed: 21321214
Am J Physiol Gastrointest Liver Physiol. 2006 Dec;291(6):G999-1004
pubmed: 17090722
Int J Cancer. 2006 Jul 1;119(1):196-201
pubmed: 16450397
Acta Pathol Microbiol Scand. 1965;64:31-49
pubmed: 14320675
J Gastric Cancer. 2017 Sep;17(3):212-219
pubmed: 28970951
Am J Epidemiol. 2009 Aug 15;170(4):507-14
pubmed: 19584132
Viruses. 2020 Oct 28;12(11):
pubmed: 33126718
Cancer Res. 1990 Oct 15;50(20):6486-9
pubmed: 2145061
Sci Rep. 2019 May 1;9(1):6769
pubmed: 31043675
N Engl J Med. 2018 Mar 22;378(12):1154-1156
pubmed: 29562150
Gastroenterology. 2013 Sep;145(3):554-65
pubmed: 23684942
Gastrointest Endosc. 2006 Apr;63(4):570-80
pubmed: 16564854
J Pathol. 2003 Jan;199(1):36-40
pubmed: 12474224
Cancer Causes Control. 2008 Sep;19(7):689-701
pubmed: 18293090
Gastroenterology. 1995 Sep;109(3):885-8
pubmed: 7657118
World J Gastroenterol. 2014 Sep 14;20(34):11991-2006
pubmed: 25232236
Front Biosci. 1999 Mar 15;4:D286-98
pubmed: 10077541
Cancer Res. 1992 Dec 15;52(24):6735-40
pubmed: 1458460
Gan. 1984 Jun;75(6):494-501
pubmed: 6468837
JAMA Netw Open. 2021 Jul 1;4(7):e2118457
pubmed: 34309666
Gastric Cancer. 2002;5 Suppl 1:5-11
pubmed: 12772880
Am J Med. 1977 Oct;63(4):644-52
pubmed: 199063
Gut. 2010 Dec;59(12):1617-24
pubmed: 20926644
Am J Gastroenterol. 2001 Jan;96(1):16-26
pubmed: 11197247
Int J Cancer. 2003 Nov 20;107(4):629-34
pubmed: 14520702
Ann Surg Oncol. 2015 Sep;22(9):2965-71
pubmed: 25631065
Infect Immun. 2004 Jul;72(7):3925-31
pubmed: 15213136
J Natl Cancer Inst. 1991 May 1;83(9):640-3
pubmed: 2023282
Eur J Cancer Prev. 1997 Jun;6(3):226-68
pubmed: 9306073
Int J Cancer. 2009 Aug 1;125(3):666-73
pubmed: 19382179
Br J Cancer. 2011 Jan 4;104(1):198-207
pubmed: 21081930

Auteurs

Cosmin Grad (C)

Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
2 Department of Internal Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Simona Grad (S)

Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
2 Department of Internal Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Radu A Fărcaş (RA)

2 Department of Internal Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Stefan Popa (S)

Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
2 Department of Internal Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Dan L Dumitraşcu (DL)

Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
2 Department of Internal Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Classifications MeSH